Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		×
			NIOSH
			NIOSH

				All CDC
				Submit


The National Institute for Occupational Safety and Health (NIOSH)





NIOSH Investigates Workplace Outbreak of Blastomycosis						Print
																Related Pages
										On This Page
			About BlastomycosisWhat NIOSH is DoingOn Site EvaluationInitial RecommendationsMedical Survey and Environmental SamplingNext StepsAdditional Resources
The National Institute for Occupational Safety and Health (NIOSH) at the Centers for Disease Control and Prevention (CDC) is investigating a blastomycosis outbreak among workers at the Billerud Escanaba Mill, a paper mill in Escanaba, Michigan. Management from the paper mill requested a health hazard evaluation to investigate the outbreak and help to control it.
The goal of a health hazard evaluation is to learn whether workers are exposed to health or safety hazards on the job and to make recommendations to workplaces to prevent work-related injury and illness by controlling hazards. Health hazard evaluations can address many types of hazards including chemical, biological, physical, radiological, and others. Employees, employee representatives (unions), or employers can ask NIOSH to determine if health hazards are present in their workplace.About BlastomycosisBlastomycosis is an infection caused by a fungus called *Blastomyces*. The fungus lives in the environment, particularly in moist soil and in decomposing matter such as wood and leaves. In the United States, the fungus mainly lives in the midwestern, south-central, and southeastern states, particularly in areas surrounding the Ohio and Mississippi River valleys, the Great Lakes, and the Saint Lawrence River. People can get blastomycosis after breathing in the microscopic fungal spores from the air, often after participating in activities that disturb topsoil or decaying plant materials like wood or leaves. Blastomycosis does not spread through the air between people or between people and animals.What NIOSH is DoingNIOSH is conducting the health hazard evaluation to investigate the outbreak at the paper mill. NIOSH is coordinating its investigation with management from Billerud Escanaba Mill, unions representing employees, officials from the Michigan Department of Health and Human Services and Public Health Delta & Menominee Counties, and the Mycotic (fungal) Diseases Branch of the Centers for Disease Control and Prevention (CDC).On Site EvaluationA NIOSH field team traveled to the facility for an onsite evaluation on March 27–28, 2023. The NIOSH field team, consisting of a health scientist, industrial hygienist, epidemiologist, laboratorian, and medical officer, was accompanied by CDC fungal disease experts and local and state health officials. During the evaluation, the field team:
Held an opening meeting with Billerud Escanaba Mill management and union and employee representatives to discuss evaluation objectives.
Performed a walkthrough of the worksite that occupies roughly 2,200 acres. The walkthrough included a detailed guided tour of the facility to understand work processes, practices, and personal protective equipment used by employees.
Spoke with the company occupational health physician and nurse as well as employees and management to understand the work process, potential sources of exposure, and health concerns.Initial RecommendationsBased on findings during the initial onsite evaluation, NIOSH provided an interim letter to the employer, recommending the following actions to reduce the potential for exposure to *Blastomyces*while the health hazard evaluation is ongoing:
Continue to make NIOSH approved N95® disposable filtering-facepiece respirators available to all employees for voluntary use to minimize exposure to *Blastomyces*, especially for employees who have underlying medical conditions or are on medications that might impair their ability to resist infection and put them at greater risk for severe illness.
Inspect heating, ventilation, and air conditioning systems, and follow the manufacturers’ recommended maintenance schedules.
Contract with a licensed ventilation engineer or building scientist to inspect ductwork for water incursion or microbial growth.
Limit activities that involve disrupting soil, such as excavation.
Continue to encourage employees who develop symptoms to seek care from their healthcare provider.Medical Survey and Environmental SamplingNIOSH investigators traveled to Escanaba, Michigan again in late April. During this trip, investigators offered employees a *Blastomyces*urine antigen test and the opportunity to participate in a work and health questionnaire. The urine antigen test is a screening test to look for potential exposure to *Blastomyces*and may help to identify additional cases. However, a positive test alone is not enough to diagnose the illness blastomycosis. Employees with positive urinary antigen tests or possible symptoms will be advised to see their personal healthcare providers for appropriate follow up care. The questionnaire will help to better understand what factors increase workers’ risk for infection. Employee participation was voluntary.
Investigators also collected environmental samples including soil samples, dust samples, wood chips, and ventilation system filter material so they can be tested for presence of *Blastomyces.* Unfortunately, there aren’t well-established ways for doing this, so interpretation of the results might be difficult. Even though this testing may not be fully informative about the cause of the outbreak, we think it was important to try because it might help in guiding prevention and control efforts.Next StepsNIOSH investigators will continue to work closely with CDC’s Mycotic Diseases Branch and state and local health departments during this evaluation. Next steps are:
Contact people who were diagnosed with blastomycosis that investigators were unable to see during the medical survey in Escanaba to give them the opportunity to complete the confidential work and health questionnaire.
Provide all employees who participated in having the urine antigen test with their individual test results as soon as possible after they are received from the laboratory.
Begin data analysis and provide summary reports to the company as information becomes available.
Continue to support Billerud management by providing information and recommendations to protect employee health and safety during the mill’s return to operation.The evaluation will be completed as soon as possible. Following the evaluation, NIOSH will share a final report, which includes any findings and recommendations. The report will be made available to the public on the NIOSH website and shared widely with partners, including the:
Employer
Employees
Unions representing employees
Occupational Safety and Health Administration (OSHA)
Michigan OSHA-approved state plan (MIOSHA)
Public Health Delta & Menominee Counties
Michigan Department of Health and Human ServicesAdditional ResourcesPublic Health, Delta & Menominee Counties Information
							
					
							Last Reviewed:  April 19, 2023						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeNIOSH Newsroom
Features
NIOSH-Funded Research News
NIOSH in the News
NIOSH Video
Press Releases and Updates Error processing SSI file  Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue